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Abstract
Malaria-protective CD8+ T cells specific for the circumsporozoite (CS) protein are primed by dendritic cells (DCs) after
sporozoite injection by infected mosquitoes. The primed cells then eliminate parasite liver stages after recognizing the CS
epitopes presented by hepatocytes. To define the in vivo processing of CS by DCs and hepatocytes, we generated parasites
carrying a mutant CS protein containing the H-2Kb epitope SIINFEKL, and evaluated the T cell response using transgenic and
mutant mice. We determined that in both DCs and hepatocytes CS epitopes must reach the cytosol and use the TAP
transporters to access the ER. Furthermore, we used endosomal mutant (3d) and cytochrome c treated mice to address the
role of cross-presentation in the priming and effector phases of the T cell response. We determined that in DCs, CS is cross-
presented via endosomes while, conversely, in hepatocytes protein must be secreted directly into the cytosol. This suggests
that the main targets of protective CD8+ T cells are parasite proteins exported to the hepatocyte cytosol. Surprisingly,
however, secretion of the CS protein into hepatocytes was not dependent upon parasite-export (Pexel/VTS) motifs in this
protein. Together, these results indicate that the presentation of epitopes to CD8+ T cells follows distinct pathways in DCs
when the immune response is induced and in hepatocytes during the effector phase.
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Introduction
Immunization with irradiated Plasmodium sporozoites to induce
sterile protection against live parasite challenge is a powerful
model for malaria vaccination [1]. Protective immunity is
mediated in part by CD8+ T cells specific for the circumsporozoite
(CS) protein of Plasmodium [2,3]. Plasmodium specific CD8+ T cells
have been shown to be primed by dendritic cells (DCs) [4,5,6,7].
In particular, we have found that after sporozoite inoculation into
the dermis by infected mosquitoes, antigen is presented by DCs in
the skin-draining lymph node to initiate the CD8+ T cell response
[4]. Primed CD8+ T cells then exit the priming site and migrate to
the liver where they can eliminate infection after recognizing
antigen presented by hepatocytes [4]. Thus CD8+ T cell mediated
immunity requires antigen presentation by two different cell types
– DCs and hepatocytes. Determining how DCs and hepatocytes
process and present Plasmodium antigens is essential for the rational
identification of vaccine candidates. Since immunization with
irradiated sporozoites represents the gold standard for malaria
vaccination it is important to know which sporozoite antigens are
presented by DCs. Perhaps more vital still, is to understand which
molecules are presented by hepatocytes, as only those molecules
presented to effector cells can be the targets of protective
immunity.
Microbial and tumor epitopes presented by MHC class I usually
derive from proteins in the cytosol that are proteolytically cleaved
into small peptides by the proteasome. These peptides are
translocated from the cytosol into the ER by the TAP transporter
for loading onto class I MHC molecules, which then traffic
towards the cell surface (reviewed in [8]). Many parasites,
however, reside within a parasitophorous vacuole (PV) and their
proteins are not necessarily secreted into the host cytosol. The
processing and presentation of intracellular parasite antigens is
therefore complex and still poorly understood. Toxoplasma gondii
antigens have been reported to reach the cytosol for class I
processing via fusion of the PV and the host ER; from the host ER
antigens may be retrotranslocated into the host cytosol for
processing [9]. Leishmania major antigens may bypass the host
cytosol altogether as antigen presentation appears to be TAP
independent. Instead it is believed that L. major-derived peptides
are directly loaded onto MHC Class I in the phagolysosome [10].
The in vivo processing of Plasmodium sporozoite or liver stage
antigens has not been studied. Unlike Toxoplasma or Leishmania,
Plasmodium does not infect professional APCs and it is not known
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how DCs acquire sporozoite antigen. Likewise, the presentation of
antigens by hepatocytes to effector cells is also poorly understood.
In-vitro evidence suggests that hepatocytes are capable of
presenting Plasmodium antigen and that this may be proteasome
dependent [11], requiring the export of parasite antigen to the
hepatocyte cytosol by unknown mechanisms. It has been proposed
that Pexel/VTS motifs, known to be important for the export of
proteins out of the PV in Plasmodium blood stages [12,13], could
also be involved in the transport of liver stage antigens to the
hepatocyte cytosol for processing and presentation by class I MHC
[14].
In this study we aimed to identify key cellular and molecular
features of the antigen processing pathways employed by DCs and
hepatocytes. We aimed to determine if Plasmodium CS processing
requires the use of the cytoplasmic TAP dependent pathway to
transport the processed epitope from the cytosol to the ER and
allow binding of the peptide to class I MHC. In addition, we
wanted to investigate whether the CS antigen is phagocytosed by
presenting cells or if it is directly deposited or secreted into the
cytosol of DCs or hepatocytes. To address these questions we
generated P. berghei parasites that express a mutant CS protein
containing the model SIINFEKL H-2Kb restricted epitope. Using
this parasite in conjunction with knockout and mutant mice we
have been able to generate the clearest picture to date of the
processing of the CS protein from both sporozoite and liver stages.
Results
Generation of P. berghei CS5M parasites expressing
SIINFEKL in the CS protein
A major obstacle to determining how Plasmodium antigens are
presented to T cells is the lack of defined H-2b restricted epitopes
which severely limits in vivo studies, as many transgenic mice,
which are critical to study basic aspects of immunology, are
generated on a C57Bl/6 (H-2b) background. To overcome this, we
generated P. berghei CS5M parasites in which the endogenous CS
gene was replaced with a modified CS gene carrying 5 mutations
that changed the natural H-2Kd restricted epitope SYIPSAEKI to
SIINFEKL, an H-2Kb restricted epitope (Figure 1A and B). P.
berghei CS5M parasites were apparently normal as they infected
mosquitoes and mice similarly to parental P. berghei ANKA (Figure
S1). Most importantly P. berghei CS5M parasites stimulated a robust
SIINFEKL specific response in C57Bl/6 mice upon immunization
(Figure 1C), and activated SIINFEKL-specific CD8+ T cells from
previously generated TCR transgenic mice [15] were able to
eliminate the liver stages of P. berghei CS5M (Figure 1D).
It is important to emphasize that our approach differs
significantly from the more common strategy of inserting an
entire foreign gene into a parasite and then tracking the immune
responses to the foreign molecule. In the P. berghei CS5M parasite
SIINFEKL is inserted in place of a well-defined natural epitope,
leaving intact the neighboring residues to ensure correct
proteasomal processing, thus the model epitope is presented
exactly as the natural CS epitope. This makes the P. berghei CS5M
parasite an excellent system in which to study antigen processing
and presentation. Moreover, we anticipate that P. berghei CS5M will
be a powerful tool for use in future studies of antigen specific
immune responses to malaria sporozoites.
The presentation of sporozoite antigen by DCs is TAP
dependent
We initiated our studies on the presentation of Plasmodium
antigen by investigating whether DCs present irradiated sporozo-
ite antigen via the canonical TAP dependent pathway. Wild type
and TAP-1 deficient mice [16] were immunized intra-dermally in
the ear with sporozoites and 2 days later CD11c+ DCs were
isolated from the draining lymph nodes. To assess antigen
presentation the DCs were co-cultured with CFSE-labeled
SIINFEKL specific transgenic cells. Antigen presentation was
quantified by measuring the expansion of the transgenic cell
population 3 days after immunization. While DCs isolated from
wild type animals induced extensive proliferation of the SIIN-
FEKL specific cells, DCs from immunized TAP-1 deficient
animals were unable to induce proliferation (Figure 2A). The
failure of TAP-1 deficient DCs to induce proliferation could only
be due to a processing defect as TAP-1 deficient DCs pulsed with
exogenous SIINFEKL peptide were fully capable of inducing
antigen specific T cell proliferation (Figure S2).
To determine if TAP-1 is required in vivo after immunization via
the natural route of infection, wild-type and TAP-1 deficient
animals that had received SIINFEKL specific TCR transgenic
CD8+ T cells were immunized by the bites of irradiated
mosquitoes infected with P. berghei CS5M parasites. We observed
a robust antigen specific CD8+ T cell response after immunization
of wild type mice; however, immunized TAP-1 deficient animals
failed to mount a significant CD8+ T cell response in either the
draining LN, spleen or liver (Figure 2B). Together these data
indicate that the presentation of the CS protein by DCs is strictly
TAP dependent.
Sporozoite antigen presentation by DCs occurs via an
endosome-to-cytosol pathway
Given that the priming of sporozoite specific T cells is TAP
dependent, the CS protein must reach the cytosol of the DC for
antigen processing. Since Plasmodium parasites have not been
observed to productively infect DCs [17,18] it is not obvious how
sporozoite antigen accesses the DC cytosol. One possibility is that
CS antigen from sporozoites is cross-presented via an endosome-
to-cytosol pathway in which sporozoite antigen is phagocytosed
and then retrotranslocated into the cytosol [19]. Alternatively, CS
may be deposited in DCs during the process of cell traversal - a
process in which sporozoites pass through the cytosol of cells,
without forming a vacuole around themselves [20,21,22].
To distinguish between these possibilities we evaluated the
induction of CD8+ T cell responses in animals which have a
Author Summary
Malaria causes the deaths of 0.5–2 million people each
year, mainly in Africa. A safe and effective vaccine is likely
needed for the control or eradication of this disease.
Immunization by irradiated malaria-infected mosquitoes
has been shown to protect people against malaria.
Irradiated parasites do not divide and cause infection but
are capable of activating specialized killer cells called CD8+
T cells, which can protect against live parasites. Because
vaccinating people with irradiated mosquitoes is not
practical, we wanted to understand which parasite
molecules are targeted by CD8+ T cells. These molecules
may then be formulated into a safe and effective vaccine.
CD8+ T cells do not automatically recognize every parasite
molecule, but instead fragments of parasite proteins must
be displayed on the surface of infected cells to be seen by
CD8+ T cells. Our data show that CD8+ T cells recognize
parasite proteins secreted by the parasite into the infected
cell. This suggests that such proteins could be important
components of malaria vaccines.
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single-point mutation in the molecule Unc93B1 (3d mice). This
mutation causes several impairments to endosome function
including defects in signaling via the endosomal TLRs and in
cross presentation [23]. We reasoned that if there were defects in
T cell priming in these animals it would strongly indicate a role for
endosomes in antigen processing by DCs. We found that DCs
isolated from immunized 3d mice were less capable of priming
SIINFEKL specific T cells in vitro compared to wild type controls
(Figure 3A). This defect appears to be in the processing of antigen,
as exogenous peptide is efficiently presented by DCs from 3d mice
(Figure S2). Nonetheless, ex vivo antigen presentation assays
provide only a snapshot of sporozoite antigen presentation at a
single time point whereas we have recently shown that prolonged
antigen presentation is required for full T cell priming [24]. Thus
we assessed T cell priming in vivo after immunization by mosquito
bites. We found that the difference observed in ex vivo experiments
was amplified in vivo as 3d mice had severely decreased SIINFEKL
specific responses in the spleen and liver compared to wild type
mice (Figure 3B).
The role of endosomes in the presentation of sporozoite antigen
by DCs was further confirmed in experiments in which cross-
presenting DCs subsets were depleted in vivo by treatment with
cytochrome c (cyt c; Figure S3) [25,26,27]. Upon taking up cyt c
cross-presenting DCs retrotranslocate it into the cytosol where it
can induce apoptosis. In contrast non cross-presenting cell subsets
are unaffected as they break down any cyt c that has been taken up
in lysosomes. In agreement with the data from 3d mice we found
significant reductions in the priming of SIINFEKL specific T cells
in cyt c treated animals after immunization via mosquito bites
(Figure 3C). Together these data demonstrate that the majority of
sporozoite antigen is probably processed via the endosome-to-
cytosol pathway.
Opsonization of parasites inhibits their presentation by
DCs
Given that the presentation of sporozoite antigen by DCs occurs
via the endosome, we hypothesized that opsonization of parasites
might enhance the priming of CD8+ T cells [28,29]. Accordingly
we incubated parasites with the anti-CS mAb 3D11 [30] prior to
immunization. Unexpectedly, we found that opsonized parasites
induced much reduced proliferation of CD8+ T cells compared to
sporozoites treated with irrelevant antibody [31] (Figure 4). This
intriguing result indicates that opsonization inhibits rather than
potentiates the delivery of sporozoite derived CS protein to the
DC class I processing pathway. This surprising result is not
completely unprecedented – opsonized T. gondii parasites appear
Figure 1. Generation of P. berghei CS5M parasites. A. Scheme of the strategy used for gene targeting of the replacement CS5M molecule.
Location of primers used for PCR verification of recombination is given below (primer sequences given in Table S1). Restriction sites are K – KpnI; Se –
SexAI; Bs – BsmF1; X – XhoI; S – SacI. B. Verification of clones – i. genomic DNA from cloned parasites was amplified with the primers CS1 and S8R
(giving a 1526 bp product) to verify recombination at the 59 end, and the primers CS4 and PB106 (giving a 1001 bp product) to verify recombination
at the 39 end, genomic DNA from P. berghei ANKA was used as a control. ii. To verify that the parasite population was clonal, genomic DNA was
amplified within the CS sequence with the primers F205 and R904 to give a 699 bp product. The PCR product was then digested with SexA1, which
cuts in the P. berghei CS5M product, but not the P. berghei ANKA product, to yield fragments of 510 and 186 bp. C. C57Bl/6 mice were immunized i.d.
in the right ear with 56104 irradiated P. berghei ANKA or P. berghei CS5M parasites. 10 days later the SIINFEKL-specific immune response in the spleen,
draining lymph nodes and liver (pooled) was determined by ELISPOT (mean 6 SEM; n = 3, data from one of 3 similar experiments; ** = P,0.01). D.
C57Bl/6 mice received 26106 SIINFEKL-specific effector CD8+ T cells 3 hours prior to challenge with 56103 P. berghei ANKA or P. berghei CS5M
sporozoites (grey bars); control mice did not receive effector cells (black bars). 40 hours later livers were taken and parasite rRNA concentration
determined by real-time PCR (mean 6 SEM; n = 4, data from one of 2 similar experiments, ns = not significant).
doi:10.1371/journal.ppat.1001318.g001
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to be taken up by DCs via complement and Fc receptors and
directed away from the cross presenting pathway and towards
break down by lysosomes [9]. To determine if this occurs after
opsonization of Plasmodium sporozoites we also treated sporozoites
with F(ab9)2 fragments of the 3D11 mAb which cannot be
recognized by Fc receptors and do not efficiently fix complement.
However 3D11 F(ab9)2 fragments were as efficient as intact
antibody at inhibiting T cell priming. Thus it may be that
opsonization (and F(ab9)2 treatment) affect T cell priming by
immobilizing parasites [32] and thus interfering with a number of
processes which may be important for T cell priming. These
include parasite migration to the skin draining lymph nodes,
invasion of cells in the skin and the shedding of antigen from the
sporozoite surface [4,17,33].
Hepatocytes present Plasmodium antigens that are
directly secreted into the cytosol
Because effector cells must kill infected hepatocytes, it is also
required that hepatocytes present processed antigen to CD8+ T
cells. Therefore, in addition to DCs, we were also interested in
determining how hepatocytes process antigen for presentation to
effector cells. To determine if antigen is processed by hepatocytes
via the same endosome-to-cytosol pathway employed by DCs,
activated SIINFEKL specific CD8+ T cells were transferred to
TAP-1 deficient, 3d and cyt c treated mice that were subsequently
infected with P. berghei CS5M parasites. The read-out for epitope
presentation is T-cell mediated inhibition of liver stage develop-
ment i.e. if the epitope is presented, activated CD8+ T cells will
recognize it and will eliminate liver stage parasites. We also tried to
visualize antigen presentation by immuno-fluorescence with the
mAb 25-D1.16 which recognizes Kb-SIINFEKL complexes [34];
however, in common with other researchers we found that this
technique was not sensitive enough to detect epitopes on the
surface of parasite infected cells [35].
Using our in vivo functional assay we found that effector CD8+ T
cells had no inhibitory effect on parasite development in the livers
of TAP-1 deficient animals while they were fully capable of
eliminating parasites in wild type mice (Figure 5A), clearly
indicating that in hepatocytes, as in DCs, CS must reach the
cytosol for antigen processing. However, in sharp contrast to DCs,
we found that hepatocytes do not process antigen via endosomes
since effector CD8+ T cells were capable of efficiently eliminating
parasites from the livers of 3d or cyt c treated mice (Figure 5B and
C). Thus hepatocytes unlike DCs do not appear to process antigen
by an endosome to cytosol pathway, rather, hepatocytes present
antigen that has been deposited or secreted by the parasite directly
into the cytosol.
Presentation of CS by infected hepatocytes and DCs does
not require functional Pexel/VTS motifs
Our findings that antigen presentation in hepatocytes requires
CS to enter the host cytosol but is independent of the endosomal
pathway, raise the question as to how CS traffics to the hepatocyte
cytosol. A previous report in which the 2 Pexel/VTS motifs in the
N terminal domain of CS were mutated, suggested that CS export
to the cytosol was eliminated in the absence of functional Pexel/
VTS motifs [14]. To determine whether Pexel/VTS motifs are
critical for the entry of CS into the class I processing pathway of
infected hepatocytes we generated P. berghei CS5M parasites that
carried mutations in key residues of both Pexel/VTS motifs as well
as the SIINFEKL epitope (P. berghei CS5MDP1–2; Figure S4). We
mutated the Pexel/VTS sequences to the sequence that was
previously suggested to abolish CS export into the cytoplasm of
infected hepatocytes [14]. In fact we were able to observe punctate
Figure 2. Antigen presentation by DCs is TAP dependent. A. CFSE profiles of SIINFEKL specific transgenic cells after incubation with dLN DCs
isolated from C57Bl/6 (wild type) or TAP-1 deficient animals 2 days after immunization with 56104 P. berghei CS5M sporozoites/ear. Data are based on
pooled DCs from 6–8 mice per group; values at top left are the percent of cells that have divided. B. TAP1-/- and C57Bl/6 (wild type) mice received
26103 naı̈ve SIINFEKL-specific CD8+ T cells prior to being fed on by 10–20 P. berghei CS5M infected mosquitoes. 10 days later the mice were sacrificed
and the expansion of SIINFEKL-specific cells in the spleen and liver determined. Data are pooled from 2 similar experiments (mean 6 SEM; n = 6).
doi:10.1371/journal.ppat.1001318.g002
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staining of CS in the cytosol of both P. berghei CS5M and P. berghei
CS5MDP1–2 infected Hepa1-6 cells (Figure 6A and B), and more
importantly, we found that the P. berghei CS5MDP1–2 parasites were
killed as efficiently as P. berghei CS5M by effector CD8+ T cells
(Figure 6C). This indicates that Pexel/VTS motifs are not required
for the entry of CS into the cytosol of hepatocytes for antigen
presentation to effector CD8+ T cells. However, in agreement
with the previous study we did observe that parasites with mutated
Pexel/VTS motifs in the CS protein have a ,10-fold decrease in
infectivity (Figure 6C). Finally we found that DCs efficiently
present the epitope from the CS protein of parasites lacking the
Pexel/VTS motifs (Figure 6D). This was not entirely unexpected
as our previous findings suggested that DCs likely acquire the CS
antigen by phagocytosis which is unlikely to be affected by host cell
targeting sequences.
Discussion
In this study we demonstrate that the process of antigen
presentation required for the priming of sporozoite specific T cells
and for the elimination of liver stage parasites are distinct. The
difference in antigen presentation between DCs and hepatocytes
has important consequences for malaria vaccine development
based on irradiated sporozoites. If other Plasmodium antigens are
processed similarly to CS, it is likely that DCs, which acquire
antigens by phagocytosis, could stimulate T cell responses to a
Figure 3. Antigen presentation by DCs occurs via the endosome-to-cytosol pathway. A. i. DCs were purified from the ear draining LN of
C57Bl/6 (wild type) or Unc93B13d animals 2 days after immunization with 56104 P. berghei CS5M sporozoites/ear and incubated with CFSE labeled
SIINFEKL specific trangenic cells. i Representative CFSE profiles of the transgenic cells 3 days after immunization values at top left are the percent of
cells that have divided (mean 6 SEM). ii. Mean number of cells that had divided at least one or twice in 3 independent experiments after incubation
with DCs from wild type (black bars) or 3d mice (gray bars) (mean 6 SEM; * = P,0.05; for each group in each experiment pooled DCs from 6–8
immunized animals were used). B. 3d (endosomal mutant) and C57Bl/6 mice received 26103 naı̈ve SIINFEKL-specific cells prior to being fed on by 10–
20 P. berghei CS5M infected mosquitoes. 10 days later the mice were sacrificed and the expansion of SIINFEKL-specific cells in the spleen and liver
determined. Data are pooled from 2 similar experiments (mean 6 SEM; n = 6; *** = P,0.001). C. C57Bl/6 mice received 26103 naı̈ve SIINFEKL-specific
cells prior to being fed on by 10–20 P. berghei CS5M infected mosquitoes. Treated mice received 15 mg of horse cyt c (Sigma) for 3 days starting on
the day before immunization, control mice received vehicle alone (PBS). 10 days later the mice were sacrificed and the expansion of SIINFEKL-specific
cells in the spleen and liver determined. Data are pooled from 2 similar experiments (mean 6 SEM; n = 6).
doi:10.1371/journal.ppat.1001318.g003
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broad range of secreted and non-secreted antigens. In contrast
hepatocytes can only present antigens that are secreted into the
cytosol of infected or traversed cells; these antigens are, however,
the potential targets of protective immunity as they induce effector
cells to eliminate liver stage parasites. Thus, irradiated sporozoites
may induce a range of irrelevant as well as protective immune
responses. Moreover it is possible that irradiated sporozoites will
fail to induce protective responses to various liver stage antigens
presented by hepatocytes, that are not expressed by sporozoites.
This appears to be the case for the liver stage antigen Hep17:
irradiated sporozoites do not induce detectable Hep17 specific
CD8+ T cells; however, vaccine-induced T cells specific for this
antigen are protective against Plasmodium liver stages [36].
We observed that both T cell priming and parasite elimination
by T cells were strictly TAP dependent. Thus in both DCs and
hepatocytes antigen must reach the cytosol for presentation. In
DCs this appears to occur via an endosome-to-cytosol pathway as
determined by two independent in vivo methodologies: the use of
3d mice and treatment of mice with cyt c. However, unlike the
defect in TAP1 deficient mice, the reduction in T cell priming in
both 3d and cyt c treated mice was not complete. This may
indicate that a small amount of antigen is directly deposited in the
cytosol of DCs by traversing sporozoites. Alternatively cross-
presentation may not be fully ablated in these models. 3d mice
carry a single point mutation in one molecule (Unc93B1) which
may retain some residual functionality [23], while the depletion of
cross-presenting DCs by cyt c may not be absolute, particularly in
the lymph nodes. The function of Unc93B1 in antigen
presentation is not clear, though it may be involved in
translocating elements of the cross-presentation machinery to the
endosome similar to the way it mediates the movement of TLRs to
endosomes [37]. An intriguing recent study showed that 3d mice
were highly susceptible to T. gondii infection [38]. The authors
suggest that this was not due to an impairment of CD8+ T cell
Figure 4. Antigen presentation by DCs is inhibited by opsonization. Mice received 56105 CFSE labeled SIINFEKL-specific cells one day prior
to immunization i.d. with 56104 P. berghei CS5M parasites in the right ear that had either been treated for 20 minutes with 100 mg/ml of either anti-P.
knowlesi CS (2G3), anti-P. berghei CS (3D11) or F(ab9)2 fragments prepared from the 3D11 antibody. Three days later the mice were sacrificed and ear
draining lymph nodes taken. A. Representative CFSE profiles of the SIINFEKL-specific population, values are the mean % of cells that had proliferated
6 SEM in one of 4 similar experiments. B. The size of the expansion of the transferred SIINFEKL-specific cells (mean 6 SEM n = 3; representative of 4
similar experiments).
doi:10.1371/journal.ppat.1001318.g004
Figure 5. Antigen is directly presented to effector cells by hepatocytes. A. C57Bl/6 or TAP1-/- mice received 26106 SIINFEKL-specific effector
CD8+ T cells 3 hours prior to challenge with 56103 P. berghei CS5M sporozoites (grey bars); control mice did not receive effector cells (black bars). 40
hours later livers were taken and parasite rRNA concentration determined by real-time PCR (mean 6 SEM; n = 4, data from one of 2 similar
experiments). B. C57Bl/6 or 3d mice received 26106 SIINFEKL specific effector CD8+ T cells 3 hours prior to challenge with 56103 P. berghei CS5M
sporozoites (grey bars); control mice did not receive effector cells (black bars). 40 hours later livers were taken and parasite rRNA concentration
determined by real-time PCR (mean 6 SEM; n = 5, data from one of 2 similar experiments). C. Cyt c or PBS treated C57Bl/6 mice received 26106
SIINFEKL specific effector CD8+ T cells 3 hours prior to challenge with 56103 P. berghei CS5M sporozoites (grey bars); control mice did not receive
effector cells (black bars). Treated mice received 15 mg cyt c for 3 days starting the day before challenge. 40 hours after challenge livers were taken
and parasite rRNA concentration determined by real-time PCR (mean 6 SEM; n = 4).
doi:10.1371/journal.ppat.1001318.g005
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control of parasites as the activation of CD8+ T cells appeared
normal in 3d mice – however they were only able to look at bulk T
cell populations and not antigen specific cells.
Further research will be required to determine what receptors
DCs use to take up sporozoites and which pattern recognition
molecules interact with sporozoites to facilitate cross presentation.
One unexpected finding was that opsonization of sporozoites did
not enhance the presentation of the CS antigen by DCs. One
hypothesis is that opsonization may immobilize parasites [32] and
thus interfere with a variety of processes that may be important for
T cell priming including antigen shedding, and migration to the
draining lymph nodes for presentation [4,17,33]. Alternatively
opsonization may prevent parasites from infecting cells in the skin
where they could continue to provide antigen to the immune
system [18,39]. The inability of DCs to present antigen from
immobilized parasites may explain why irradiated parasites are
capable of inducing a protective CD8+ T cell response, but heat
killed parasites are not [3,40]. These data also have important
implications for vaccine design since they imply that there would
be difficulties in priming or boosting sporozoite specific CD8+ T
cell responses in individuals with high anti-CS antibody titers.
Thus it may be hard to induce effective CD8+ T cell responses in
individuals who have already been naturally exposed to parasites
or immunized with vaccines such as RTS,S that are designed to
induce strong anti-sporozoite antibody responses [41].
Using the 3d and cyt c treated mice we showed that in contrast
to T cell priming, parasite elimination was unaffected in mice with
reduced capacity to cross-present antigen. This is in agreement
with the findings of a previous in vitro study [11] which found no
evidence for endosomes having a role in antigen presentation by
infected cells. The previous study also showed that proteasome
and Golgi inhibitors blocked antigen presentation, which is
compatible with our finding that antigen presentation occurs via
the classical TAP-dependent pathway [11]. Together these data
suggest that cell killing occurs only after direct antigen presenta-
tion by the infected hepatocyte itself.
A key direction for future research will be to identify how
antigens enter the host cell for presentation. We were unable to
Figure 6. Pexel/VTS motifs are not required for the presentation of CD8+ epitopes in the CS protein. A. Fluorescence microscopy of
Hepa1–6 cells 6 hours after infection with P. berghei CS5M and P. berghei CS5MDP1–2. Parasites were visualized by staining with anti-Plasmodium HSP70
(red) and the localization of the CS protein determined by staining with the 3D11 mAb (green). B. % of parasites with CS visible in the host cell based
on microscopy performed as in A, (mean 6 SEM; data are based on 3 independent experiments per parasite strain with 50 parasites imaged per
experiment). C. C57Bl/6 mice received 26106 SIINFEKL specific effector CD8+ T cells 3 hours prior to challenge with 56103 P. berghei CS5M or P.
berghei CS5MDP1–2 sporozoites (grey bars); control mice did not receive effector cells (black bars). 40 hours later livers were taken and parasite rRNA
concentration determined by real-time PCR (mean 6 SEM; n = 4, data from one of 2 similar experiments). D. C57Bl/6 mice received 56105 CFSE
labeled naı̈ve SIINFEKL-specific cells one day prior to immunization i.d. with 56104 P. berghei CS5M or P. berghei CS5MDP1–2 parasites in the right ear.
Three days later the mice were sacrificed and ear draining lymph nodes taken. Antigen presentation in vivo was inferred by determining the % of
SIINFEKL-specific cells that had proliferated (mean 6 SEM; n = 3, data representative of 2 similar experiments).
doi:10.1371/journal.ppat.1001318.g006
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find a role for Pexel/VTS motifs in targeting the CS protein to the
host cell cytosol as suggested by a previous study [14]. Our data
are based on fluorescence microscopy 6 hours post-infection when
the highest amounts of CS can be observed in the cytosol [42,43]
and, more importantly, our functional assay to measure the
elimination of parasites by T cells. The fact that Pexel/VTS motifs
are not required for the entry of CS to the class I processing
pathway suggests that liver stage proteins may be exported to the
hepatocyte by other mechanisms. In particular, it suggests that the
CS protein may contain another motif that facilitates its export out
of the PV into the infected host cell. Alternatively, liver-stage
antigens might also be exported to the class I processing pathway if
the Plasmodium PV can fuse with the hepatocyte ER as appears to
occur in Toxoplasma infected DCs [9].
Together our data provide the most complete description to
date of the processing of sporozoite and liver stage antigen. Using
the P. berghei CS5M parasite we have demonstrated that DCs cross-
present sporozoite antigen via an endosome-to-cytosol pathway.
Of most importance, we show that CS must be delivered to the
hepatocyte cytosol for presentation to effector cells. If this is true
for other antigens, it is likely that antigens secreted into the
hepatocytes of either infected or traversed cells constitute the
major targets of anti-liver stage CD8+ T cell mediated immunity.
Secretion to the hepatocyte is likely a complex process given our
finding that Pexel/VTS motifs are not required for the entry of CS
to the class I processing pathway; however, unraveling this process
will be key to the identification of vaccine candidates.
Materials and Methods
Ethics statement
All animal procedures were approved by the Institutional
Animal Care and Use Committee of the Johns Hopkins University
(Protocol Number MO09H41) following the National Institutes of
Health guidelines for animal housing and care.
Mice
5–8 week old female C57Bl/6 were purchased from NCI
(Frederick, MD). TAP-1 deficient animals were purchased from
Jackson (Bar Harbor, ME). Unc93B13d mice were obtained from
the Mutant Mouse Resource Center (University of California,
Davis, CA). OT-1 mice (carrying a transgene specific for the
SIINFEKL epitope) were kindly provided by David Sacks
(Laboratory of Parasitic Disease, National Institute of Allergy
and Infectious Disease, Bethesda, MD).
Parasites and transfections
P. berghei CS5M parasites were generated by transfection of P.
berghei ANKA with the linearized pR-CS5M plasmid as previously
described [44]. pR-CS5M was derived from the plasmid pR-CSwt
[45] as follows. A Kpn1-Xho1 fragment including the entire CS
gene was excised from pR-CSwt into a pBluescript SK-
(Stratagene) backbone to generate the plasmid pIC-CSwt. A
SexA1 site was introduced by mutation of G to A at position 714
in the CS gene (silent in Gln238) and a BsmF1 site was introduced
by a mutation of T to C at position 810 (silent in Asp270) using the
QuikChange XL site directed mutagenesis kit (Stratagene). The
SexA1-BsmF1 fragment was excised and replaced with a ,100 bp
insert including the SIINFEKL epitope in place of the SYIP-
SAEKI sequence (formed from the oligos S8ins F and S8insR; see
Table S1) to generate the plasmid pIC-CS5M. The Kpn1-Xho1
fragment from pIC-CS5M was excised and ligated into the
backbone of pR-CSwt to generate the pR-CS5M plasmid. pR-
CS5M was linearized with the enzymes Kpn1 and Sac1.
P. berghei CS5MDP1–2 parasites were generated similarly to P. berghei
CS5M (Figure S1). The plasmid pR-CS5MDP1–2 was generated as
follows. Arg32 and Leu34 in the CS gene on the pIC-CS5M plasmid
were mutated to Alanines by using the QuikChange site directed
mutagenesis kit with the primers PEXEL1 F and PEXEL1 R (see
Table S1), which include a Bsm1 site. Arg66 and Leu68 were
mutated similarly with the primers PEXEL2 F and PEXEL2 R that
include an ApaB1 site. The resulting plasmid was designated pIC-
CS5MDP1–2. The Kpn1-Xho1 fragment of the pIC-CS5MDP1–2
plasmid was ligated into the pR-CSwt backbone to generate the pR-
CS5MDP1–2 plasmid used for transfection.
Quantification of T cell priming by DCs ex vivo
Lymph node and spleen myeloid DCs were prepared essentially
as described [46]. Briefly, spleens or lymph nodes from immunized
mice or naive mice were taken, chopped finely and digested with
1 mg/ml collagenase. The single cell suspension of spleen cells was
then separated over a Nycodenz gradient (density, 1.075 g/ml)
and the DC-rich low-density fraction was taken. To further enrich
the DC population, negative selection was performed on the
collected fraction using magnetic bead separation with anti-CD3,
anti-GR1, anti TER119, anti-B220 and anti-Thy1.2 antibodies.
Final purity of CD11c+ DC was about 70%. To assess Ag
presentation ex vivo, splenic myeloid DCs (16105) were mixed with
56104 purified naive CFSE-labeled CD8+-transgenic cells in a
single V-bottom well of a 96-well plate. 60–65 h later, the cells
were harvested, and CFSE dilution in the transgenic cell
population was used as a measure of Ag presentation.
Quantification of T cell priming by DCs in vivo
Where possible SIINFEKL-specific T cell priming was
measured after immunization by the bites of 10–20 irradiated
mosquitoes. Prior to biting, a low number (26103) of CD45.1+
OT-1 cells were transferred to mice and the expansion of the
CD45.1+ CD8+ (SIINFEKL-specific) population were measured
by flow cytometry 10 days later to allow time for the responses to
reach detectable levels. In some experiments it was necessary to
perform immunizations with needle injected sporozoites (e.g.
where the sporozoites were treated with antibodies prior to
immunization). In these experiments 56105 congenic CD45.1+
OT-1 cells were adoptively into mice, which were immunized the
following day. The cells would be labeled with 0.6 mM CFSE using
the Vybrant Cell Tracker kit according to the manufacturer’s
instructions (Invitrogen Life Technologies), and antigen presenta-
tion was inferred from proliferation of CD45.1+ CD8+ cells in the
draining lymph nodes after 3 days. Use of a high number of
transgenic cells is acceptable in these experiments as we are using
the cells as a readout of antigen presentation not measuring
particular T cell phenotypes. ELISPOTs to measure peptide-
specific IFN-c secreting cells were performed as described [47] and
used to detect endogenous SIINFEKL responses.
Preparation of F(ab9)2 fragments
F(ab9)2 fragments from the 3D11 mAb (class: mouse IgG1) were
prepared by incubation with immobilized Ficin in the presence of
4 mM cysteine according to the manufacturer’s instructions (Pierce).
F(ab9)2 fragments were isolated from intact antibody and Fc fragments
by passing twice over a Protein A column. Purity of F(ab9)2 fragments
was verified by SDS-PAGE under non-reducing conditions.
Generation of SIINFEKL-specific effector T cells
SIINFEKL-specific effector cells were purified from mice that
had received 56105 naı̈ve CD45.1+ OT-1 cells and then been
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immunized with 26106 pfu VV-OVA [48]. 8–10 days later
spleens were taken from the immunized mice and the lymphocytes
were purified by spinning over lympholyte M (Cedarlane
Laboratories). A total of 26106 effector/SIINFEKL specific
CD8+ T cells were transferred to each recipient mouse.
Quantification of parasite RNA
Quantification of liver stage parasites was performed as
previously described [49]. Briefly, 40 hours after challenge, livers
were excised and parasite load was determined by quantitative
PCR for P. berghei 18S rRNA using SYBR Green (Applied
Biosystems).
Cell isolation and preparation of samples for flow
cytometry
Single cell suspensions of lymphocytes were obtained by
grinding spleen cells or lymph node cells between the ground
ends of two microscope slides and filtering twice through 100 mm
nylon mesh. Liver lymphocytes were isolated from perfused livers
by grinding, filtration through a 70 mm mesh and separation over
a 35% percol gradient as described [50].
Fluorescence microscopy
Hepa1-6 cells were grown on coverslips in a 48 well plate and
allowed to reach ,80% confluence prior to infection with ,36104
parasites. 6 hours later the slides were washed and fixed for 15
minutes with 4% formaldehyde prior to permeablilization with
100% methanol for 10 minutes. The cells were then blocked with
3% BSA for 45 minutes. The parasite cytosol was labeled with anti-
Plasmodium HSP70 mAbs [51] followed by secondary staining with
Alexa594 anti-mouse IgG (Molecular Probes). The cells were then
stained with anti-P. berghei CS mAb (3D11) directly conjugated to
FITC. Slides were mounted with ProLong antifade with DAPI
(Molecular Probes). Images were acquired on a Nikon Eclipse 90i
microscope with a Hamamatsu Orca-ER camera attachment using
Volocity software (Perkin Elmer). Images were analyzed and
assembled using ImageJ software (open source from NIH).
Data analysis
Statistical analysis was performed using Prism 4 software
(GraphPad Software), unless otherwise stated, means were
compared by two-tailed Student’s t tests. Analysis of all flow
cytometry data was performed using FlowJo software (TreeStar).
Supporting Information
Figure S1 Infectivity P. berghei CS5M parasites in the mosquito
and mouse. A. Salivary glands were dissected from mosquitoes 21
days after blood feeding with P. berghei ANKA or P. berghei CS5M
and sporozoites extracted and counted. Results are based on 3
independent feedings per group with .10 mosquitoes dissected
per feeding (mean 6 SEM; ns = not significant). B. Parasite load
in the livers of mice infected with P. berghei ANKA or P. berghei
CS5M was assessed 40 hours after infection (mean 6 SEM; n = 4,
data from one of 2 similar experiments).
Found at: doi:10.1371/journal.ppat.1001318.s001 (0.40 MB TIF)
Figure S2 DCs from TAP-1 deficient and 3d mice can efficiently
present exogenous peptide. CFSE profiles of SIINFEKL specific
transgenic cells after incubation with spleen DCs isolated from
C57Bl/6 (wild type), TAP-1 deficient or 3d mice that had been
pulsed with 10mg/ml SIINFEKL peptide. As a control transgenic
cells were also incubated with unpulsed DCs from naive wild type
mice. Data are based on pooled DCs from 3 mice per group;
values at top left are the percent of cells that have divided. Data is
representative of two independent experiments per group.
Found at: doi:10.1371/journal.ppat.1001318.s002 (0.33 MB TIF)
Figure S3 Cyt c treatment selectively ablates cross-presenting
DC populations. Mice were treated with 15 mg horse cyt c in PBS
or PBS alone, administered i.v. and 24 hours later the number of
CD4+ DCs (CD4+, CD11c+, CD82, CD32) CD8+ DCs (CD8+,
CD11c+, CD42, CD32) and double negative (DN) DCs (CD42,
CD82. CD11c+, CD32) was assessed in the spleen (A) and skin
draining LNs (B) by FACs.
Found at: doi:10.1371/journal.ppat.1001318.s003 (0.77 MB TIF)
Figure S4 Generation of P. berghei CS5MDP1–2 parasites. A.
Scheme of the strategy used for gene targeting of the replacement
CS5MDP1–2 molecule. Open reading frames are represented by
boxes, untranslated regions by solid lines, plasmid vectors
sequences by dotted lines. Black represents wild type genomic
sequences, blue represents homologous sequences in the targeting
construct, red represents sequence associated with the selectable
marker, and yellow represents mutations in the CS gene. Location
of primers used for PCR verification of recombination is given
below (primer sequences given in Table S1). Restriction sites are
K - KpnI; B - BsmI; A - ApaBI; Se - SexAI; Bs - BsmF1; X - XhoI;
S - SacI. B. Verification of clones - i. genomic DNA from cloned
parasites was amplified with the primers CS1 and S8R (giving a
1526 bp product) to verify recombination at the 59 end and the
primers CS4 and PB106 (giving a 1001 bp product) to verify
recombination at the 39 end, genomic DNA from P. berghei ANKA
was used as a control. ii To verify that parasite populations was
clonal genomic DNA was amplified within the CS sequence with
the primers F205 and R904 to give an 699 bp product in P. berghei
ANKA and 696 bp product in P. berghei CS5MDP1–2 (which has one
codon less). The PCR product was then digested with SexA1
which cuts in the P. berghei CS5MDP1–2 product, but not the P.
berghei ANKA product, to yield fragments of 510 and 186 bp. iii
To verify that the parasites carried mutations in the PEXEL
domains, the CS1 and S8R PCR product was digested with the
enzymes BsmI which cuts in the mutated Pexel1 motif to yield 618
and 845 bp fragments and ApaBI which cuts in the mutated
Pexel2 motif to yield 581 and 945 bp fragments. The PCR
product from the P. berghei CS5M parasite was used as a control.
Found at: doi:10.1371/journal.ppat.1001318.s004 (1.46 MB TIF)
Table S1 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.ppat.1001318.s005 (0.05 MB
DOC)
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